phosphorus has been researched along with medroxyprogesterone acetate in 2 studies
| Studies (phosphorus) | Trials (phosphorus) | Recent Studies (post-2010) (phosphorus) | Studies (medroxyprogesterone acetate) | Trials (medroxyprogesterone acetate) | Recent Studies (post-2010) (medroxyprogesterone acetate) |
|---|---|---|---|---|---|
| 48,074 | 1,126 | 17,139 | 5,123 | 1,115 | 1,099 |
| Protein | Taxonomy | phosphorus (IC50) | medroxyprogesterone acetate (IC50) |
|---|---|---|---|
| Estrogen receptor | Homo sapiens (human) | 0.924 | |
| Glucocorticoid receptor | Homo sapiens (human) | 0.013 | |
| Progesterone receptor | Homo sapiens (human) | 2.5081 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.019 | |
| Mineralocorticoid receptor | Homo sapiens (human) | 1.197 | |
| Androgen receptor | Homo sapiens (human) | 0.0061 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 0.279 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.019 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.019 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.019 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 1.197 | |
| Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 1.4059 | |
| Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | 4.0405 | |
| Aldo-keto reductase family 1 member C1 | Homo sapiens (human) | 1.8 | |
| Estrogen receptor beta | Homo sapiens (human) | 0.924 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cosman, F; Lindsay, R; Nieves, J; Shen, V | 1 |
| Heikkinen, J; Hietala, EL; Larmas, M; Väänänen, HK | 1 |
1 trial(s) available for phosphorus and medroxyprogesterone acetate
| Article | Year |
|---|---|
Oral 1,25-dihydroxyvitamin D administration in osteoporotic women: effects of estrogen therapy.
Topics: Absorptiometry, Photon; Administration, Oral; Aged; Body Height; Body Weight; Bone Density; Bone Development; Bone Resorption; Calcitriol; Cross-Sectional Studies; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Femur Neck; Humans; Lumbar Vertebrae; Medroxyprogesterone Acetate; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus | 1995 |
1 other study(ies) available for phosphorus and medroxyprogesterone acetate
| Article | Year |
|---|---|
Effect of postmenopausal estrogen treatment on some diagnostic salivary variables.
Topics: Bacteria; Calcium; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Menopause; Phosphorus; Placebos; Prospective Studies; Saliva; Secretory Rate | 1993 |